Category: Clinical Breakthroughs
-
Longer Shifts For Surgical Residents Are Safe For Patients
A landmark national study has shown allowing surgical residents the flexibility to work longer hours does not pose any greater risk to patients.
-
Assessing Drug Treatment for Sickest Hepatitis C Patients
A phase III clinical trial including Northwestern Medicine investigator Steven Flamm, MD, tested a new combination of antiviral drugs for hepatitis C patients with late-stage cirrhosis.
-
Common Heart Medication Doesn’t Work for All
Patients with a specific type of heart failure were less active when taking a commonly prescribed nitrate medication thought to improve exercise capacity, according to a recent study co-authored by Northwestern Medicine investigator Sanjiv Shah, MD.
-
Priceless Gifts
Five recipients receive seven organs from a single donor, all over the course of 34 hours.
-
Studying Treatment for Diabetic Retinopathy
A randomized clinical trial showed an intravitreous drug may be an alternative treatment for some patients with proliferative diabetic retinopathy.
-
Improving Movement After Stroke and Brain Injury
Injections of botulinum toxin improved active arm movement for stroke and brain trauma patients in a clinical trial that involved Northwestern Medicine co-investigator Christina Marciniak, MD, ’85 GME.
-
Children With Common Allergies Have Twice the Heart Disease Risk
Children with allergic disease have about twice the rate of high blood pressure and high cholesterol, according to a new Northwestern Medicine study.
-
Influencing Hospitals, Clinicians and Policymakers to Improve Patient Care
Karl Bilimoria, MD, director of the Northwestern Surgical Outcomes and Quality Improvement Center, discusses his team’s research to elevate the quality of care patients receive.
-
Examining Optimal Dosage for Heart Failure Drug
A clinical trial led by Northwestern Medicine scientist Mihai Gheorghiade, MD, opens the door for further investigation of a new drug to treat the more than one million patients in the United States hospitalized for heart failure every year.
-
New Strategy Reduces Side Effects In Parkinson’s Treatment
Northwestern Medicine scientists have identified a novel strategy for reducing the side effects of the drug levodopa, which is commonly used to treat the stiffness, tremors and poor muscle control of Parkinson’s disease.
